<?xml version="1.0" encoding="UTF-8"?>
<document id="26637696">
	<sentence id="s1" text="The sideroblastic anemias are a heterogeneous group of inherited and acquired disorders characterized by the presence of ring sideroblasts in the bone marrow.">
		<entity id="s1.e1" charOffset="32-45"
			type="HP" text="heterogeneous" ontology_id="HP_0001425"/>
		<entity id="s1.e2" charOffset="74-77"
			type="GENE" text="red" ontology_id="8444"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Refractory anemia with ring sideroblasts (RARS) is a myelodysplastic syndrome characterized mainly by anemia attributable to ineffective erythropoiesis.">
		<entity id="s2.e1" charOffset="42-46"
			type="GENE" text="RARS" ontology_id="5917"/>
		<entity id="s2.e2" charOffset="125-151"
			type="HP" text="ineffective erythropoiesis" ontology_id="HP_0010972"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Inhibitors of molecules of the transforming growth factor-Î² superfamily have been shown recently to target ineffective erythropoiesis and ameliorate anemia both in animal models of myelodysplastic syndrome and in RARS patients.">
		<entity id="s3.e1" charOffset="107-133"
			type="HP" text="ineffective erythropoiesis" ontology_id="HP_0010972"/>
		<entity id="s3.e2" charOffset="213-217"
			type="GENE" text="RARS" ontology_id="5917"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
</document>
